MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1–3 Prior Lines of Therapy (LOT)
Authors:
- Jens HillengassJHJens Hillengass
- Adam D CohenACAdam D Cohen
- Michel DelforgeMDMichel Delforge
- Hermann EinseleHEHermann Einsele
- Hartmut GoldschmidtHGHartmut Goldschmidt
- Katja WeiselKWKatja Weisel
- Marc-Steffen RaabMRMarc-Steffen Raab
- Christof ScheidCSChristof Scheid
- Jordan M SchecterJSJordan M Schecter
- Kevin C de BragancaKBKevin C de Braganca
- Helen VarsosHVHelen Varsos
- Tzu-Min YehTYTzu-Min Yeh
- 20 September 2022
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22, S411